ERBB2 and breast carcinoma: In addition, Tuna et al. 46 found that HER2 could upregulate WT1 expression through the Akt signaling pathway, promoting breast cancer cell proliferation and inhibiting apoptosis, suggesting that WT1 can promote breast cancer cell proliferation.